Search Media Items

NOMID, or neonatal-onset multisystem inflammatory disease, is a rare disease that is often fatal. This video tells the story of Kayla Martínez, who was diagnosed with NOMID as a baby. It also tells the story of a treatment for NOMID that was discovered by Dr. Raphaela Goldbach-Mansky at the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health.

List of Registries Personal Stories For Parents and Children For Health Care Providers Resources for Trial Sites Educational Resources Glossary of Common Terms If You Have a Question In the News Taking a swing at Alzheimer’s disease Ollie Doolittle helps researchers learn more about the aging brain Ollie and Vernie Doolittle with their arms around each other. Ollie and Vernie Doolittle. 81-year-old Ollie still plays on three softball teams.(Photo credit: UC Davis Alzheimer’s Center) The bond between Ollie and Vernie Doolittle has endured though 60 years of marriage and military service during two wars. They still never go to bed angry (most of the time).

Personal Clinical Research Trials Personal Stories Volunteer and Researchers

Children are not little adults, yet they are often given medicines and treatments that were only tested in adults. There is a lot of evidence that children’s developing brains and bodies can respond to medicines and treatments differently than how adults respond. The way to get the best treatments for children is through research designed specifically for them.

You can play an active role in your health care by talking to your doctor. Clear and honest communication between you and your physician can help you both make smart choices about your health.

Welcome to the NIH’s Financial Operations Website. On this page you will find the most recent information about NIH’s financial operations plans for the fiscal year, links to the financial management plans of NIH institutes and centers, and answers to frequently asked questions. We hope that you will find the information on this site helpful.

Common food additives called emulsifiers promoted colitis and metabolic syndrome in mice by altering gut microbes.

In a mouse study, 2 drugs already on the market activated stem cells and repaired the type of brain damage seen in multiple sclerosis (MS).

A common over-the-counter allergy drug lowered hepatitis C virus levels in infected mice.

Researchers mapped different language impairments to specific brain regions to reveal the basic organization of our language system.

NIH Interim Grant General Conditions (PDF - 635 KB) - February 5, 2015 (Superseded by the NIHGPS on 3/31/2015).

The page limits for most forms sections are listed below, organized by Activity Code.

Genetic discrimination occurs if people are treated unfairly because of differences in their DNA that increase their chances of getting a certain disease. For example, a health insurer might refuse to give coverage to a woman who has a DNA difference that raises her odds of getting breast cancer. Employers also could use DNA information to decide whether to hire or fire workers.

The ELSI Research Program is the largest dedicated extramural bioethics research program at the NIH. Its budget has grown from $1.57 million in fiscal year 1990 to over $18 million in fiscal year 2014. The program has awarded over $335 million in research support, and has funded more than 500 projects, which collectively, have resulted in thousands of publications.

"The National Institutes of Health (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program is part of a congressionally funded effort to encourage and speed the development of new drugs for rare and neglected diseases. The federal budget for fiscal 2009 dedicated $24 million to establish this initiative.